Literature DB >> 25363332

Damage to histaminergic tuberomammillary neurons and other hypothalamic neurons with traumatic brain injury.

Philipp O Valko1, Yury V Gavrilov, Mihoko Yamamoto, Kristen Finn, Hasini Reddy, Johannes Haybaeck, Serge Weis, Thomas E Scammell, Christian R Baumann.   

Abstract

The need for increased sleep after traumatic brain injury is a common and disabling complaint, yet its etiology is unknown. Previous studies have demonstrated diffuse damage to various hypothalamic systems, but the integrity of the histaminergic tuberomammillary nucleus, a major arousal-promoting system located in the posterior hypothalamus, has never been examined in head trauma patients. Here, we demonstrate that severe head trauma is associated with a marked loss (41%) of histaminergic neurons. Reduced histamine signaling may contribute to increased sleep need, and therapies that enhance histaminergic tone may improve arousal after head trauma or other conditions.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25363332     DOI: 10.1002/ana.24298

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Hypocretin Mediates Sleep and Wake Disturbances in a Mouse Model of Traumatic Brain Injury.

Authors:  Hannah E Thomasy; Mark R Opp
Journal:  J Neurotrauma       Date:  2018-10-03       Impact factor: 5.269

2.  Sleep Quantity and Quality during Acute Concussion: A Pilot Study.

Authors:  Adam C Raikes; Sydney Y Schaefer
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

3.  Inactivation of the Tuberomammillary Nucleus by GABAA Receptor Agonist Promotes Slow Wave Sleep in Freely Moving Rats and Histamine-Treated Rats.

Authors:  Jun-Fan Xie; Kun Fan; Can Wang; Peng Xie; Min Hou; Le Xin; Guang-Fu Cui; Lin-Xin Wang; Yu-Feng Shao; Yi-Ping Hou
Journal:  Neurochem Res       Date:  2017-04-01       Impact factor: 3.996

Review 4.  Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction.

Authors:  Juan Piantino; Miranda M Lim; Craig D Newgard; Jeffrey Iliff
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

Review 5.  Sleep, Sleep Disorders, and Circadian Health following Mild Traumatic Brain Injury in Adults: Review and Research Agenda.

Authors:  Emerson M Wickwire; David M Schnyer; Anne Germain; Scott G Williams; Christopher J Lettieri; Ashlee B McKeon; Steven M Scharf; Ryan Stocker; Jennifer Albrecht; Neeraj Badjatia; Amy J Markowitz; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2018-08-24       Impact factor: 5.269

Review 6.  Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies.

Authors:  Danielle K Sandsmark; Jonathan E Elliott; Miranda M Lim
Journal:  Sleep       Date:  2017-05-01       Impact factor: 5.849

Review 7.  Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.

Authors:  Shi-Bin Li; Jeff R Jones; Luis de Lecea
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

8.  Damage to Arousal-Promoting Brainstem Neurons with Traumatic Brain Injury.

Authors:  Philipp O Valko; Yuri V Gavrilov; Mihoko Yamamoto; Daniela Noaín; Hasini Reddy; Johannes Haybaeck; Serge Weis; Christian R Baumann; Thomas E Scammell
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

9.  Sleep Disturbances in Traumatic Brain Injury: A Meta-Analysis.

Authors:  Natalie Grima; Jennie Ponsford; Shantha M Rajaratnam; Darren Mansfield; Matthew P Pase
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

10.  Sleep, Sleep Disorders, and Mild Traumatic Brain Injury. What We Know and What We Need to Know: Findings from a National Working Group.

Authors:  Emerson M Wickwire; Scott G Williams; Thomas Roth; Vincent F Capaldi; Michael Jaffe; Margaret Moline; Gholam K Motamedi; Gregory W Morgan; Vincent Mysliwiec; Anne Germain; Renee M Pazdan; Reuven Ferziger; Thomas J Balkin; Margaret E MacDonald; Thomas A Macek; Michael R Yochelson; Steven M Scharf; Christopher J Lettieri
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.